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A recent report in Genes & Development by Boutz et al. (2007) demonstrates that muscle specific
microRNAs (miRNAs) downregulate the alternative splicing regulator nPTB during skeletal muscle
differentiation to control a potential network of splicing transitions. The results illustrate how two
modes of posttranscriptional regulation combine to direct skeletal muscle development.Two posttranscriptional regulatory
mechanisms, RNAi and alternative
splicing, have burst onto the gene reg-
ulation scene. MicroRNAs (miRNAs)
are small noncoding RNAs that bind
mRNAs via imperfect base pairing
and typically repress protein expres-
sion. Biocomputational and experi-
mental analyses have identified po-
tential networks of mRNA targets for
individual miRNAs, many of which are
conserved across metazoan species.
Current efforts include validation of
miRNA-mRNA targets and determina-
tion of how miRNA regulation inte-
grates with the intricate molecular cir-
cuitry that controls gene expression
and determines cell behavior.
Alternative splicing is the predomi-
nant mechanism that generates pro-
teome diversity. Recent microarray
and large-scale RT-PCR analyses
have demonstrated extensive regula-
tion of alternative splicing events in re-
sponse to a wide range of stimuli. Reg-
ulated splicing produces a dynamic
proteome by modulating expression
of functionally diverse protein isoforms
and by providing an on/off switch
using premature termination codons
and nonsense-mediated decay (Blen-
cowe, 2006). Regulation of alternative
splicing is combinatorial; however,
this does not preclude clear-cut identi-
fication of dominant regulators. For ex-
ample, a mouse knockout for muscle-
blind-like 1 (MBNL1) has revealed its
role in regulating a subset of splicing
transitions during the first weeks of
postnatal skeletal muscle develop-ment (Lin et al., 2006). Similarly, the
neuron-specific Nova2 regulates a
large number of splicing events related
to synapse function (Ule et al., 2005).
Among the best-characterized splic-
ing regulators is polypyrimidine tract
binding protein (PTB) and its paralog,
nPTB. PTB iswidely expressed in adult
tissues, and nPTB expression is re-
stricted to brain, testis, and, at lower
levels, heart and skeletal muscle.
PTB/nPTB are involved in regulating
neuron- and muscle-specific splicing
events and do so by binding to a se-
quencemotif located within the introns
that flank the regulated exon. In their
study, Boutz et al. (2007) used the
mouse C2C12 myoblast cell line to in-
vestigate how PTB/nPTB activity is
modulated during skeletal muscle dif-
ferentiation. C2C12 cells rapidly prolif-
erate in mitogen-rich medium and,
when switched to mitogen-deficient
medium, they undergo a magnificent
transformation in which they align
and fuse to form characteristic multi-
nucleated syncytial muscle fibers. A
huge number of transcriptional and
posttranscriptional changes takeplace
during differentiation, including a large
number of splicing transitions. A few
of these splicing events were known
PTB/nPTB targets, raising the possi-
bility that PTB/nPTB coordinates a
subset of splicing transitions during
muscle differentiation.
The authors found that PTB and
nPTB are expressed in C2C12 cells
and the levels of both proteins de-
crease during differentiation; nPTBDevelopmental Cell 12becomes undetectable. While PTB
mRNA levels decrease in parallel with
protein, nPTBmRNA levels actually in-
crease, indicating regulation of trans-
lation and/or protein stability. NPTB
and, as it turns out, PTB mRNAs con-
tain binding sites for miR-133 and
two related miRNAs, miR-1 and miR-
206, which are coexpressed with miR-
133 due to processing from the same
precursors. MiR-133 and miR-1/206
are specific to heart and skeletal mus-
cle, and their roles in striated muscle
development are conserved in Dro-
sophila and mammals (Nguyen and
Frasch, 2006). MiR-133 and miR-1/
206 expression is induced during
C2C12 differentiation, correlating with
the loss of nPTB protein. The authors
clearly demonstrate that miR-133 and
miR-1/206 regulate expression of
nPTB protein during C2C12 differen-
tiation via base pairing within the
mRNA. The critical follow-up experi-
ment was to block the functions of
endogenous miR-133 or miR-133 plus
miR-1/206, which increased nPTB
(and PTB) protein levels (though not
to predifferentiation levels) and re-
versed a set of splicing changes to-
ward the undifferentiated patterns.
A key question is whether these
splicing changes are direct targets of
nPTB/PTB. After all, miR-133 and/or
miR-1 have a large number of putative
mRNA targets, and blocking these
miRNAs could affect splicing by
mechanisms that are independent of
nPTB/PTB expression. However, RNAi
knockdowns of nPTB and PTB in, February 2007 ª2007 Elsevier Inc. 171
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that the miRNA-dependent splicing
transitions were also nPTB/PTB sensi-
tive in a way that was consistent with
the loss of nPTB/PTB during differenti-
ation. There are some subtleties that
hint at additional levels of complexity,
however. A block of miR-133 alone
had a stronger effect on most splicing
events than a block of miR-133 plus
miR-1/206, while nPTB and PTB pro-
tein steady-state levels were affected
more by the latter than the former.
This result suggests that these splicing
events are dependent upon factors in
addition to nPTB/PTB steady-state
levels. Given the unknown intricacies
of the regulatory roles of miR-133 and
miR-1/206 during muscle differentia-
tion, complexities are expected. For
example, PTB acts in conjunction
with antagonistic regulators as well
as coregulators. Expression of these
factors could be integrated into differ-
ent miRNA circuitry.
These results support the notion that
miRNAs preside over implementationA Matter of Som
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Embryonic stem (ES) cells are blasto-
cyst-derived pluripotent cells capable
of apparently limitless proliferation.
Unlike the transient inner cell mass,
however, ES cells are able to remain
in an undifferentiated state indefinitely
when cultured under appropriate con-
ditions. A number of previous reports
have implicated multiple transcription
factors in the control of pluripotency.
172 Developmental Cell 12, February 200rather than determination of cell fate
decisions (Tomczak et al., 2004).
MiR-133 andmiR-1/206 are potentially
regulated by the myogenic transcrip-
tion factors MyoD and myogenin (Rao
et al., 2006), accounting for their rela-
tively late expression during differenti-
ation compared to other myogenic
factors, such as myogenin and p21
(Chen et al., 2006). In addition, many
of the miR-133 and miR-1/206 targets
predicted by the authors are not in-
volved in cellular determination, but
rather are metabolic, signaling, and
structural genes. This is also the case
for many of the splicing targets of
nPTB/PTB, so that the biological tar-
gets that are directly and indirectly
affected by miR-133 and miR-1/206
appear to modulate and maintain, but
not establish, the differentiated state.
This study provides insight into the
upstream events controlling a set of
coordinated alternative splicing deci-
sions that are part of a dramatic
cellular transition. It is an important
advance toward understanding howe Importins: Nucle
ll Maintenance an
, RIKEN Center for Developmental Biology, K
.jp
ology reports an unexpected role f
cells. The authors show how switc
ction in the nuclear import of key tra
entiation.
Maintaining the pluripotency of ES
cells requires a strictly controlled level
of Oct3/4; a 2-fold increase in protein
level results in differentiation into prim-
itive endoderm, while a 50% reduction
drives the cells into the trophectoder-
mal lineage (Niwa et al., 2000). Sox2
functions as a co-factor of Oct3/4 in
this context, and the complex they
form acts on the promoters of various
7 ª2007 Elsevier Inc.posttranscriptional regulatory mecha-
nisms combine to control a develop-
mental program.
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or nuclear transport proteins in
hing of importin-a subtypes ex-
nscription factors that regulate
ES cell-specific genes. Interestingly,
Sox2 also plays a crucial role in neural
differentiation by acting as co-factor
for another POU-domain protein,
Brn2. The primary importance of a lim-
ited set of transcription factors in the
establishment of pluripotency was re-
cently highlighted by the conversion
of fibroblasts into ES-like cells by intro-
duction with just four factors: Oct3/4,
